The Asia Pacific Surgical Sealants and Adhesives Market size is valued at USD 394 million in 2020 and is expected to grow at a CAGR of 9.8 % to reach USD 689 million by 2025 from 2020 to 2025. It is the fastest-growing market capturing 19% of the global market share.
In modern surgical procedures sealants and adhesives have become useful accompaniments as they have evolved over the years. Their efficacy, usability in repairing injured tissues, safety and support for wounds obtained during surgery are the causes for their wide-scale adoption.
Rising concerns to reduce surgical wounds along with growing demand for surgical services are the primary causes for market growth. Approximately 235 million major surgeries are carried out globally per year as per the WHO estimates which augurs well for the market. It is because surgical procedures are usually accompanied by the risk of wound infection, tissue damage or excessive bleeding.
The limiting factors for market growth are high costs, cumbersome regulatory procedures and stringent rules of compliance.
Asia Pacific has the highest CAGR. The creation of a sustainable health system because of the ongoing transformation of healthcare delivery systems into advanced value-based healthcare practices is the primary cause attributable to the observable trend mentioned above. This makes better facilities available at cheaper rates and promotes the use of novel techniques in surgeries and other healthcare practices. Secondary factors include increasing medical tourism, growing per capita income, the presence of less stringent regulations and the rise in investment by major players in this region.
Asia Pacific Surgical Sealants and Adhesives Market has been segmented and sub-segmented into the following categories
Top Companies dominating the Asia Pacific Surgical Sealants and Adhesives Market Profiled in the Report are CryoLife, Inc, Johnson & Johnson, Ethicon, Inc., Baxter International, Inc, and C.R. Bard, Inc, Cohera Medical, Inc. Ocular Therapuetix, Inc, Vivostat A/S and Sealants Ltd, Medtronic plc, Sanofi Group, B. Braun Melsungen AG
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Natural/Biological Sealants and Adhesives
5.1.2.1 Natural/Biological Sealants and Adhesives, By Type
5.1.2.1.1 Polypeptide/Protein-Based Sealants and Adhesives
5.1.2.1.1.1 Fibrin Based
5.1.2.1.1.2 Collagen Based
5.1.2.1.1.3 Gelatin Based
5.1.2.1.1.4 Albumin Based
5.1.2.1.2 Polysaccharide Based Sealants and Adhesives
5.1.2.1.2.1 Chitosan Based
5.1.2.1.2.2 Other Polysaccharide Based
5.1.2.2 Natural/Biological Sealants and Adhesives, By Origin
5.1.2.2.1 Human Blood-Based
5.1.2.2.2 Animal-Based
5.1.3 Synthetic and Semisynthetic Sealants and Adhesives
5.1.3.1 Cyanoacrylates
5.1.3.2 Polyethylene Glycol Based Hydrogel
5.1.3.3 Urethane-Based Adhesives
5.1.3.4 Other Synthetic Sealants and Adhesives
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Indication
5.2.1 Introduction
5.2.2 Surgical Hemostasis
5.2.3 Tissue Sealing
5.2.4 Tissue Engineering
5.2.5 Y-o-Y Growth Analysis, By Indication
5.2.6 Market Attractiveness Analysis, By Indication
5.2.7 Market Share Analysis, By Indication
5.3 Application
5.3.1 Introduction
5.3.2 Central Nervous System (CNS) Surgeries
5.3.3 General Surgeries
5.3.4 Cardiovascular Surgeries
5.3.5 Orthopedic Surgeries
5.3.6 Cosmetic Surgeries
5.3.7 Ophthalmic Surgeries
5.3.8 Urological Surgeries
5.3.9 Pulmonary Surgeries
5.3.10 Other Applications
5.3.11 Y-o-Y Growth Analysis, By Application
5.3.12 Market Attractiveness Analysis, By Application
5.3.13 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Indication
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Indication
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Indication
6.1.5.4 By Application
6.2 India
6.3 China
6.4 Japan
6.5 Australia
6.6 South Korea
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Baxter International, Inc. (U.S.)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Johnson & Johnson (Ethicon, Inc.; U.S.)
8.3 CryoLife, Inc. (U.S.)
8.4 C. R. Bard
8.5 Aastrom Biosciences
8.6 Medtronic plc (U.S.)
8.7 Sanofi Group (France)
8.8 B. Braun Melsungen AG (Germany)
8.9 Cohera Medical
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
